High fever and evidence of a virus? Caution, it still may be Kawasaki disease

November 5, 2012, Nationwide Children's Hospital

Clinicians should take caution when diagnosing a child who has a high fever and whose tests show evidence of adenovirus, and not assume the virus is responsible for Kawasaki-like symptoms. According to a new study from Nationwide Children's Hospital appearing in Clinical Infectious Diseases, adenovirus detection is not uncommon among children with Kawasaki disease.

Kawasaki disease is a rare but serious condition in children that involves inflammation of the blood vessels, specifically the heart vessels that supply the or coronary arteries. It is the most common cause of pediatric acquired heart disease in the developed world. Children with Kawasaki disease or illness caused by adenoviruses often first present with a high and persistent fever. Early diagnosis for Kawasaki disease before the tenth day of fever is essential to prevent sequelae in the heart.

"Kawasaki disease and acute adenoviral infection can present with many of the same clinical characteristics," says Preeti Jaggi, MD, member of the Section of Infectious Diseases at Nationwide Children's and lead study author. "Given the similarities, human adenovirus infection is one of the most frequent conditions included on the differential diagnosis when considering Kawasaki disease." However, few data are available regarding the differences in frequency, and types of detectable human adenovirus in Kawasaki disease patients and in children who have adenovirus disease that mimicks Kawasaki disease.

The study aimed to determine whether there are differences in the amount of human adenovirus in the upper airway in children with human adenovirus infection versus those diagnosed with Kawasaki disease. Dr. Jaggi and her team compared Kawasaki disease patients who were positive for human adenovirus infection with other patients diagnosed with human during a two year period at Nationwide Children's. Among 77 Kawasaki disease patients, nearly 13 percent had human adenovirus detected.

"Evidence suggests that human adenovirus strains can persist in pediatric adenoids and tonsils and are capable of low level shedding. PCR analysis can detect non-replicating virus," says Dr. Jaggi, also assistant professor of Clinical Pediatrics at The Ohio State University College of Medicine. "This may explain why PCR, but not viral culture, could detect human adenovirus in these Kawasaki disease patients."

The findings indicate that detection of human adenovirus in a patient with suspected Kawasaki disease should be interpreted with caution. "Detection of human adenovirus in these patients is fairly common and does not exclude the diagnosis of Kawasaki disease," says Dr. Jaggi.

According to Dr. Jaggi, quantitative PCR, culture and human adenovirus typing methods may help distinguish human adenovirus disease mimicking Kawasaki disease from with accompanying human adenovirus detection.

Explore further: Researchers link Kawasaki Disease in childhood with increased risk of adult heart disease

Related Stories

Researchers link Kawasaki Disease in childhood with increased risk of adult heart disease

July 17, 2012
Cedars-Sinai researchers have linked Kawasaki Disease, a serious childhood illness that causes inflammation of blood vessels throughout the body, with early-onset and accelerated atherosclerosis, a leading cause of heart ...

Study finds Filipino children in San Diego County at higher risk for Kawasaki disease

May 6, 2011
While children of all ethnicities can contract Kawasaki disease (KD), a study led by researchers at the Kawasaki Disease Research Center at the University of California, San Diego and Rady Children's Hospital-San Diego finds ...

Facebook saves the life of a child

July 18, 2011
Deborah Copaken Kogan’s Mother’s Day wasn’t exactly what she was hoping for when she woke up to discover her 4-year-old son Leo was sick with a rash. She posted a status message on the social networking site, ...

Study could help improve gene therapy for heart disease, cancer

October 12, 2011
A Loyola University Chicago Stritch School of Medicine study could lead to improved gene therapies for conditions such as heart disease and cancer as well as more effective vaccines for tuberculosis, malaria and other diseases.

Recommended for you

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Flu may be spread just by breathing, new study shows; coughing and sneezing not required

January 18, 2018
It is easier to spread the influenza virus (flu) than previously thought, according to a new University of Maryland-led study released today. People commonly believe that they can catch the flu by exposure to droplets from ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

Fresh approach to tuberculosis vaccine offers better protection

January 17, 2018
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.